Journals / International Journal of Medical Biochemistry / 2022 / Cilt: 5 - Sayı: 2

Evaluation of oxidative stress in gout disease; thiol-disulfide homeostasis and ischemia-modified albumin levels

Pages
109–115
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additional studies are needed to identify sources of oxidative stress in gout.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Gout is a common and easily treated disease characterized by the accumulation of monosodium urate crystals in both joints and other tissues.
📊
Key Findings & Data:Monosodium urate crystals are the main stimulants for initiating and maintaining an inflammatory response.
💡
Conclusion & Impact:Additional studies are needed to identify sources of oxidative stress in gout.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Gout is a common and easily treated disease characterized by the accumulation of monosodium urate crystals in both joints and other tissues. Monosodium urate crystals are the main stimulants for initiating and maintaining an inflammatory response. Oxidative stress is also an early change in gout pathogenesis together with inflammation. This study aimed to investigate the presence of oxidative stress in gout together with thiol–disulfide homeostasis and ischemia- modified albumin (IMA) levels. We aimed to compare these parameters with inflammation marker C-reactive protein (CRP) and high-sensitivity C-reactive protein (hsCRP). Methods: Levels of native thiol, total thiol, disulfide, IMA, CRP, and hsCRP were detected in patients with gout (n=50) and healthy subjects (n=50). Student’s t-test and the Mann-Whitney U test were used for istatistical analysis. Results: Native thiol, total thiol, and index 3 (native thiol/total thiol×100) were significantly lower in the patient group, while disulfide, index 1 (disulfide/native thiol×100), index 2 disulfide/total thiol×100), IMA, CRP, and hsCRP were significantly higher. In addition, elevation in native thiol, total thiol, and disulfide levels was detected as disease duration increased. Conclusion: The present study has shown the role of oxidant damage in gout disease. Additional studies are needed to identify sources of oxidative stress in gout.

🔖

Cite This Article

YUCEL, C., EREL, O., OĞUZ, E. F., NESELİOĞLU, S., SANDIKÇI, S. C., OMMA, A., KIZILGÜN, M., BALIK, A. R., BALIK, Z. B. (2022). Evaluation of oxidative stress in gout disease; thiol-disulfide homeostasis and ischemia-modified albumin levels. International Journal of Medical Biochemistry, Cilt: 5 - Sayı: 2, 109–115. https://ajindex.com/articles/541403

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet 2021;397(10287):1843–55
  2. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011;63(10):3136–41
  3. Martillo MA, Nazzal L, Crittenden DB. The crystallization of monosodium urate. Curr Rheumatol Rep 2014;16(2):400
  4. Cronstein BN, Terkeltaub R. The inflammatory process of gout and its treatment. Arthritis Res Ther 2006;8 Suppl 1(Suppl 1):S3
  5. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440(7081):237–41
  6. Peng YJ, Lee CH, Wang CC, Salter DM, Lee HS. Pycnogenol attenuates the inflammatory and nitrosative stress on joint inflammation induced by urate crystals. Free Radic Biol Med 2012;52(4):765–74
  7. So A, Thorens B. Uric acid transport and disease. J Clin Invest 2010;120(6):1791–9
  8. Ozdemir A, Erel O. Thiol-disulphide balance: could be a new marker for thyroid cancer? J Cancer Ther 2018;9:598–604
  9. Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes - review and clinical implications. Clin Chem Lab Med 2011;49(2):177–84
  10. Yoshida M. High sensitive CRP: hsCRP. Nihon Rinsho 2011;1:503–6
  11. Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol 2015;67(10):2557–68
  12. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia- a preliminary report. J Emerg Med 2000;19(4):311–5
  13. Erel O, Neselioglu S. A novel and automated assay for thiol/ disulphide homeostasis. Clin Biochem 2014;47(18):326–32
  14. Li S, Li L, Yan H, Jiang X, Hu W, Han N, et al. Anti gouty arthritis and anti hyperuricemia properties of celery seed extracts in rodent models. Mol Med Rep 2019;20(5):4623–33
  15. Rock KL, Kataoka H, Lai JJ. Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol 2013;9(1):13–23
  16. Afonso V, Champy R, Mitrovic D, Collin P, Lomri A. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine 2007;74(4):324–9
  17. Talwalkar SS, Bon Homme M, Miller JJ, Elin RJ. Ischemia modified albumin, a marker of acute ischemic events: a pilot study. Ann Clin Lab Sci 2008;38(2):132–7.